
Pharmac Updates Access Criteria For Remdesivir
Pharmac has heard from our expert advisors and clinicians treating people with COVID-19 that we need to make further changes to the temporary access criteria for remdesivir. “On Monday 28 February Pharmac temporarily widened access criteria to remdesivir ...